SCHEMBL24254554

SCHEMBL24254554

CCc1ccc(SN(C)C)cc1NC(C)=O

nearest known ligand 0.39

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.39
MAPK1 P28482 1/20 0.36
MAPT P10636 2/20 0.36
POLB P06746 2/20 0.36
RAB9A P51151 2/20 0.36
NPC1 O15118 1/20 0.36
GAA P10253 1/20 0.36
HSD17B10 Q99714 2/20 0.35
ALDH1A1 P00352 3/20 0.35
NPSR1 Q6W5P4 1/20 0.35
KMT2A Q03164 1/20 0.34
HPGD P15428 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.33
NR4A1 P22736 1/20 0.33
TP53 P04637 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24254555 0.81 MAPK1 (0.38) TSHRMAPK1MAPTPOLBRAB9A
SCHEMBL24254515 0.76 MAPT (0.48) MAPTPOLBGAAALDH1A1KMT2A
SCHEMBL9352526 0.76 ALDH1A1 (0.47) TSHRMAPK1MAPTPOLBRAB9A
SCHEMBL24254518 0.73 ALDH1A1 (0.49) TSHRPOLBALDH1A1NPSR1KMT2A
SCHEMBL23524965 0.72 KDM4E (0.56) TSHRMAPTPOLBRAB9AGAA
SCHEMBL24254513 0.72 ALDH1A1 (0.56) MAPTRAB9ANPC1GAAALDH1A1
SCHEMBL18409424 0.70 KMT2A (0.43) MAPK1MAPTPOLBRAB9ANPC1
SCHEMBL12329332 0.70 HTT (0.52) TSHRMAPK1MAPTGAAALDH1A1
SCHEMBL12594066 0.69 ALDH1A1 (0.49) MAPTPOLBRAB9ANPC1GAA
SCHEMBL14204703 0.69 ALDH1A1 (0.40) TSHRMAPK1MAPTPOLBRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022035804-A1 SUBSTITUTED 3-AMINO-4-METHYLBENZENESULFONAMIDES AS SMALL MOLECULE INHIBITORS OF UBIQUITIN-SPECIFIC PROTEASE 28 DANA-FARBER CANCER INSTITUTE, INC. (US) 2022-02-17 WO disclosed